Patents by Inventor Martin John Evans

Martin John Evans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11304981
    Abstract: The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: April 19, 2022
    Assignee: Cell Therapy Limited
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Trevor Reginald, Ina Laura Pieper
  • Publication number: 20210032600
    Abstract: The invention relates to progenitor cells of mesodermal lineage and their use in therapy.
    Type: Application
    Filed: October 7, 2020
    Publication date: February 4, 2021
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Trevor Reginald, Ina Laura Pieper
  • Patent number: 10829739
    Abstract: The invention relates to progenitor cells of mesodermal lineage and their use in therapy.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: November 10, 2020
    Assignee: CELL THERAPY LIMITED
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Trevor Reginald, Ina Laura Pieper
  • Publication number: 20200048613
    Abstract: The invention relates to progenitor cells of mesodermal lineage and their use in therapy.
    Type: Application
    Filed: October 8, 2019
    Publication date: February 13, 2020
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Trevor Reginald, Ina Laura Pieper
  • Patent number: 10472609
    Abstract: The invention relates to progenitor cells of mesodermal lineage and their use in therapy.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: November 12, 2019
    Assignee: Cell Therapy Limited
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Reginald, Ina Laura Pieper
  • Patent number: 10316291
    Abstract: The invention relates to immuno-oncology mesodermal progenitor (ioMP) cells and their use in therapy.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: June 11, 2019
    Assignee: Cell Therapy Limited
    Inventors: Ajan Reginald, Sabena Sultan, Martin John Evans
  • Publication number: 20190160104
    Abstract: The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.
    Type: Application
    Filed: October 19, 2018
    Publication date: May 30, 2019
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Trevor Reginald, Ina Laura Pieper
  • Publication number: 20190142869
    Abstract: The invention relates to immuno-modulatory progenitor (IMP) cells and their use in therapy.
    Type: Application
    Filed: January 11, 2019
    Publication date: May 16, 2019
    Inventors: Ajan REGINALD, Martin John EVANS, Sabena SULTAN
  • Publication number: 20180355352
    Abstract: The present invention relates to the specific inhibition of gene expression in mammals by bringing the target gene into contact with double stranded RNA (dsRNA).
    Type: Application
    Filed: July 26, 2017
    Publication date: December 13, 2018
    Inventors: Magdalena Zernicka-Goetz, Florence Wianny, Martin John Evans, David Moore Glover
  • Patent number: 10117898
    Abstract: The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: November 6, 2018
    Assignee: Cell Therapy Limited
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Reginald, Ina Laura Pieper
  • Publication number: 20180216073
    Abstract: The invention relates to immuno-oncology mesodermal progenitor (ioMP) cells and their use in therapy.
    Type: Application
    Filed: August 5, 2016
    Publication date: August 2, 2018
    Inventors: Ajan Reginald, Sabena Sultan, Martin John Evans
  • Publication number: 20180085434
    Abstract: The invention concerns a composition comprising basic fibroblast growth factor and platelet derived growth factor, and its use to treat tissue damage or inhibit senescence, or promote hair growth.
    Type: Application
    Filed: March 17, 2016
    Publication date: March 29, 2018
    Inventors: Martin John Evans, Ajan Reginald, Sabena Sultan
  • Publication number: 20170326177
    Abstract: The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.
    Type: Application
    Filed: August 2, 2017
    Publication date: November 16, 2017
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Reginald, Ina Laura Pieper
  • Publication number: 20170119930
    Abstract: The invention relates to a novel chemical composition comprising living cells combined with biocompatible fibres and biocompatible components which are optimally chemically formulated to repair damaged human or animal tissue.
    Type: Application
    Filed: June 9, 2015
    Publication date: May 4, 2017
    Inventors: Martin John Evans, Ajan Reginald, Sabena Sultan
  • Publication number: 20170096667
    Abstract: The present invention relates to the specific inhibition of gene expression in mammals by bringing the target gene into contact with double stranded RNA (dsRNA).
    Type: Application
    Filed: October 14, 2016
    Publication date: April 6, 2017
    Inventors: Magdalena Zernicka-Goetz, Florence Wianny, Martin John Evans, David Moore Glover
  • Publication number: 20170080029
    Abstract: The invention relates to immuno-modulatory progenitor (IMP) cells and their use in therapy.
    Type: Application
    Filed: June 9, 2015
    Publication date: March 23, 2017
    Inventors: Ajan REGINALD, Martin John EVANS, Sabena SULTAN, Lee Phillip CHAPMAN
  • Publication number: 20160123980
    Abstract: This invention is in the field of the identification and even isolation of mesenchymal stem cells (MSCs) and other cell types by means of differential specific fluorescence activated cell sorting (FACS).
    Type: Application
    Filed: May 20, 2014
    Publication date: May 5, 2016
    Inventors: Martin John Evans, Ajan Reginald, Sabena Sultan
  • Publication number: 20150071886
    Abstract: The invention relates to progenitor cells of mesodermal lineage and their use in therapy.
    Type: Application
    Filed: July 6, 2012
    Publication date: March 12, 2015
    Applicant: CELL THERAPY LIMITED
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Reginald, Ina Laura Pieper
  • Publication number: 20150047064
    Abstract: The present invention relates to the specific inhibition of gene expression in mammals by bringing the target gene into contact with double stranded RNA (dsRNA).
    Type: Application
    Filed: October 23, 2014
    Publication date: February 12, 2015
    Inventors: Magdalena Zernicka-Goetz, Florence Wianny, Martin John Evans, David Moore Glover
  • Publication number: 20140335195
    Abstract: The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.
    Type: Application
    Filed: November 23, 2012
    Publication date: November 13, 2014
    Applicant: CELL THERAPY LIMITED
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Reginald, Ina Laura Pieper